deltatrials
Completed NA INTERVENTIONAL 2-arm NCT07196358

Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites (HepScar)

ROLE OF HEPARIN TO PREVENT HYPERTROPHIC SCARNIG IN DONOR AREA OF SPLIT THICKNESS SKIN GRAFT

Sponsor: Dr. Ruth K.M. Pfau Civil Hospital, Karachi

Updated 1 time since 2025 Last updated: Sep 21, 2025 Started: Aug 15, 2024 Primary completion: Aug 30, 2025 Completion: Sep 10, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hypertrophic Scarring and Pain, Postoperative and is currently completed. Dr. Ruth K.M. Pfau Civil Hospital, Karachi leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2025 – present · 10 months · monthly snapshotCompleted

Change History

1 version recorded
Completed — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dr. Ruth K.M. Pfau Civil Hospital, Karachi
Data source: Dr. Ruth K.M. Pfau Civil Hospital, Karachi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations